Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson's disease.
Toshiki TezukaDaisuke TaniguchiMariko SanoTomoyo ShimadaYutaka OjiTaiji TsunemiAya IkedaYuanzhe LiHiroyo YoshinoJun OgataKahori Shiba-FukushimaManabu FunayamaKenya NishiokaYuzuru ImaiNobutaka HattoriPublished in: NPJ Parkinson's disease (2022)
Missense variants in leucine-rich repeat kinase 2 (LRRK2) lead to familial and sporadic Parkinson's disease (PD). The pathological features of PD patients with LRRK2 variants differ. Here, we report an autopsy case harboring the LRRK2 G2385R, a risk variant for PD occurring mainly in Asian populations. The patient exhibited levodopa-responsive parkinsonism at the early stage and visual hallucinations at the advanced stage. The pathological study revealed diffuse Lewy bodies with neurofibrillary tangles, amyloid plaques, and mild signs of neuroinflammation. Biochemically, detergent-insoluble phospho-α-synuclein was accumulated in the frontal, temporal, entorhinal cortexes, and putamen, consistent with the pathological observations. Elevated phosphorylation of Rab10, a substrate of LRRK2, was also prominent in various brain regions. In conclusion, G2385R appears to increase LRRK2 kinase activity in the human brain, inducing a deleterious brain environment that causes Lewy body pathology.
Keyphrases
- parkinson disease
- early stage
- resting state
- protein kinase
- functional connectivity
- copy number
- white matter
- tyrosine kinase
- squamous cell carcinoma
- deep brain stimulation
- case report
- multiple sclerosis
- cerebral ischemia
- autism spectrum disorder
- radiation therapy
- late onset
- drug delivery
- intellectual disability
- low grade
- early onset
- cancer therapy
- cognitive impairment
- lps induced
- sentinel lymph node
- structural basis
- rectal cancer
- breast cancer risk